Japan To Release Mid-term Report On Reducing Cancer Mortality
This article was originally published in PharmAsia News
Japan's Council on Promoting Cancer Treatment plans to release a mid-term report this June
You may also be interested in...
The data compares the sensitivity of almost 200 diagnostics against a standardized set of samples.
The sale of BTG Specialty Pharmaceuticals to two affiliates of European specialty firm SERB leaves Boston Scientific with BTG’s interventional oncology and vascular products.
The proposed rule from the US HHS that would require its agencies to review all regulations every 10 years could distract an incoming Biden administration from the COVID-19 pandemic and will “wreak havoc” on Medicare, a senior policy analyst for the Center on Budget and Policy Priorities says.